Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,271 | 36,449 | 35,411 | 28,200 | 41,261 |
| Marketable Securities | 48,878 | 64,899 | 63,901 | 76,834 | 77,475 |
| Receivables | 5,287 | 3,406 | 2,370 | 4,255 | 3,383 |
| Inventories | 13,457 | 11,335 | 11,398 | 9,440 | 8,301 |
| TOTAL | $99,522 | $117,760 | $114,137 | $119,898 | $132,062 |
| Non-Current Assets | |||||
| PPE Net | 6,743 | 6,601 | 7,034 | 7,861 | 8,492 |
| Other Non-Current Assets | 156 | 29 | 471 | 482 | 486 |
| TOTAL | $6,899 | $6,630 | $7,505 | $8,343 | $8,978 |
| Total Assets | $106,421 | $124,390 | $121,642 | $128,241 | $141,040 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,924 | 5,608 | 5,845 | 5,379 | 3,926 |
| Accrued Expenses | 9,438 | 11,441 | 8,726 | 9,225 | 7,678 |
| Other current liabilities | 1,410 | 1,534 | 2,477 | 1,304 | 220 |
| TOTAL | $38,411 | $31,489 | $29,140 | $27,967 | $22,513 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,339 | 13,991 | 13,914 | 13,714 | 13,525 |
| Deferred Revenues | 20,639 | 12,906 | 12,092 | 12,059 | 10,689 |
| Other Non-Current Liabilities | 3,055 | 3,097 | 3,204 | 3,546 | 3,736 |
| TOTAL | $27,538 | $37,952 | $39,467 | $41,259 | $43,002 |
| Total Liabilities | $65,949 | $69,441 | $68,607 | $69,226 | $65,515 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,566 | 74,516 | 71,356 | 70,630 | 70,495 |
| Common Shares | 75 | 74 | 71 | 71 | 70 |
| Retained earnings | -701,646 | -681,473 | -662,498 | -653,335 | -634,199 |
| Other shareholders' equity | 16 | 9 | 23 | 42 | 18 |
| TOTAL | $40,472 | $54,949 | $53,035 | $59,015 | $75,525 |
| Total Liabilities And Equity | $106,421 | $124,390 | $121,642 | $128,241 | $141,040 |